Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Kewaunee Scientific (KEQU) Amortization of Deferred Charges (2025 - 2026)

Kewaunee Scientific has reported Amortization of Deferred Charges over the past 2 years, most recently at $322000.0 for Q1 2026.

Quarterly results put Amortization of Deferred Charges at $322000.0 for Q1 2026, changed N/A from a year ago — trailing twelve months through Jan 2026 was $728000.0 (changed N/A YoY), and the annual figure for FY2025 was $218000.0, changed.
Amortization of Deferred Charges for Q1 2026 was $322000.0 at Kewaunee Scientific, up from $94000.0 in the prior quarter.
Over the last five years, Amortization of Deferred Charges for KEQU hit a ceiling of $322000.0 in Q1 2026 and a floor of $94000.0 in Q3 2025.